EP3216808B1 - Hypromellose acetate succinate, method for producing the same and composition containing the same - Google Patents
Hypromellose acetate succinate, method for producing the same and composition containing the same Download PDFInfo
- Publication number
- EP3216808B1 EP3216808B1 EP17159962.4A EP17159962A EP3216808B1 EP 3216808 B1 EP3216808 B1 EP 3216808B1 EP 17159962 A EP17159962 A EP 17159962A EP 3216808 B1 EP3216808 B1 EP 3216808B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- hydroxypropyl
- hpmcas
- methyl
- etherifying agent
- acetate succinate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 title claims description 118
- 239000000203 mixture Substances 0.000 title claims description 23
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- -1 hydroxypropyl group Chemical class 0.000 claims description 91
- 239000003795 chemical substances by application Substances 0.000 claims description 75
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 63
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 62
- 229910052799 carbon Inorganic materials 0.000 claims description 62
- 238000006243 chemical reaction Methods 0.000 claims description 56
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 52
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 51
- 238000006467 substitution reaction Methods 0.000 claims description 50
- 239000003513 alkali Substances 0.000 claims description 46
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 35
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 26
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 25
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 21
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 21
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 19
- 239000008199 coating composition Substances 0.000 claims description 17
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 15
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 14
- 229920002678 cellulose Polymers 0.000 claims description 12
- 239000001913 cellulose Substances 0.000 claims description 12
- 238000002834 transmittance Methods 0.000 claims description 12
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims description 4
- 229940014800 succinic anhydride Drugs 0.000 claims description 4
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 46
- 239000000243 solution Substances 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 27
- 229940050176 methyl chloride Drugs 0.000 description 23
- 238000000576 coating method Methods 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000011248 coating agent Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 238000003756 stirring Methods 0.000 description 14
- 238000006266 etherification reaction Methods 0.000 description 13
- 235000011114 ammonium hydroxide Nutrition 0.000 description 11
- 238000006386 neutralization reaction Methods 0.000 description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000009257 reactivity Effects 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000020176 deacylation Effects 0.000 description 5
- 238000005947 deacylation reaction Methods 0.000 description 5
- 238000012691 depolymerization reaction Methods 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- 239000007962 solid dispersion Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001447 alkali salts Chemical group 0.000 description 2
- 230000002744 anti-aggregatory effect Effects 0.000 description 2
- AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Chemical compound [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 229920000875 Dissolving pulp Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007809 chemical reaction catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013267 controlled drug release Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009474 hot melt extrusion Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B3/00—Preparation of cellulose esters of organic acids
- C08B3/06—Cellulose acetate, e.g. mono-acetate, di-acetate or tri-acetate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/08—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with hydroxylated hydrocarbon radicals; Esters, ethers, or acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/10—Esters of organic acids, i.e. acylates
- C08L1/12—Cellulose acetate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/32—Cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
- C09D101/08—Cellulose derivatives
- C09D101/10—Esters of organic acids
- C09D101/12—Cellulose acetate
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
- C09D101/08—Cellulose derivatives
- C09D101/32—Cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/20—Diluents or solvents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/65—Additives macromolecular
Definitions
- the present invention relates to hypromellose acetate succinate, a method for producing the hypromellose acetate succinate, and a composition containing the hypromellose acetate succinate.
- Enteric coating material hypromellose acetate succinate which may hereinafter be also called "HPMCAS” has been widely used for the applications including a coating application, an application of controlled drug release, and an application of producing a solid dispersion containing the HPMCAS and a poorly water-soluble drug through hot melt extrusion or spray drying.
- HPMCAS Enteric coating material hypromellose acetate succinate
- HPMCAS When HPMCAS is used for coating, a variety of coating methods can be applied. Examples include coating of a solution obtained by dissolving HPMCAS in an organic solvent, aqueous dispersion coating of an aqueous dispersion obtained by dispersing fine granules of HPMCAS in water in the presence of a plasticizer, alkali-neutralized aqueous coating of HPMCAS partially neutralized with an aqueous alkali solution, and dry coating in which fine particles of HPMCAS are directly applied while spraying a plasticizer.
- HPMCAS is a polymer obtained by replacing the hydrogen atoms of the hydroxyl group of its glucose units forming a cellulose backbone with four kinds of substituents in total, wherein the two kinds of substituents are a methyl group (-CH 3 ) and a hydroxypropoxy group (-C 3 H 6 OH) for ether structures and the other two kinds of substituents are an acetyl group (-COCH 3 ) and a succinyl group (-COC 2 H 4 COOH) for ester structures (refer to a brochure by Shin-Etsu Chemical Co., Ltd. titled "Hydroxypropyl methyl cellulose acetate succinate Shin-Etsu AQOAT",.).
- An object of the invention is to provide HPMCAS which exhibits high solubility and can suppress generation of undissolved materials when it is dissolved in a solvent; a method for producing the HPMCAS; and a composition comprising the HPMCAS.
- the present inventors have proceeded with an extensive investigation with a view to achieving the above-described object.
- solubility of the HPMCAS in a solvent can be improved when a ratio of 2-position MS to 3-position MS falls within a predetermined range, wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 2-position carbon of each glucose unit of the HPMCAS has been directly replaced and the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 3-position carbon of each glucose unit of the HPMCAS has been directly replaced; and have completed the invention.
- hypromellose acetate succinate having a ratio of 2-position MS to 3-position MS of 1.2 or less, wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 2-position carbon of each glucose unit of the hypromellose acetate succinate has been directly replaced, and the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 3-position carbon of each glucose unit of the hypromellose acetate succinate has been directly replaced.
- composition comprising the hypromellose acetate succinate and a solvent.
- a method for producing hypromellose acetate succinate comprising the steps of: reacting pulp with an alkali to obtain alkali cellulose; reacting the alkali cellulose with a methyl etherifying agent and a hydroxypropyl etherifying agent to obtain hydroxypropyl methyl cellulose in such a manner that a reaction ratio of the hydroxypropyl etherifying agent is 40% or less at the time when a reaction ratio of the methyl etherifying agent is 30%, or the reaction ratio of the hydroxypropyl etherifying agent is 90% or less at the time when the reaction ratio of the methyl etherifying agent is 50%; and reacting the hydroxypropyl methyl cellulose with acetic anhydride and succinic anhydride to obtain hypromellose acetate succinate having a ratio of 2-position MS to 3-position MS of 1.2 or less, wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of
- the HPMCAS exhibits improved solubility when dissolved in a solvent, and clogging of a filter used for filtering out undissolved materials is reduced.
- the HPMCAS has a ratio of 2-position MS to 3-position MS of 1.2 or less, preferably 1.0 or less, more preferably 0.8 or less.
- the 2-position MS means a molar substitution of hydroxypropyl group by which the hydrogen atom of the hydroxyl group on the 2-position carbon of each glucose unit of the HPMCAS has been directly replaced.
- the 3-position MS means a molar substitution of hydroxypropyl group by which the hydrogen atom of the hydroxyl group on the 3-position carbon of each glucose unit of HPMCAS has been directly replaced.
- the lower limit of the ratio of the 2-position MS to 3-position MS is not particularly limited.
- the lower limit of the ratio is preferably 0.1 or more.
- the molar substitution 2-position MS of hydroxypropyl group by which the hydrogen atom of the hydroxyl group on the 2-position carbon of each glucose unit has been directly replaced specifically means that the hydrogen atom of the hydroxyl group on the 2-position carbon, among three substitutable hydroxyl groups in each glucose unit, has been replaced by hydroxypropyl or methoxypropyl group.
- the 2-position MS specifically means a total of the following degrees of substitution: (1) a degree of substitution of hydroxypropyl or methoxypropyl group by which the hydrogen atom of the hydroxyl group on the 2-position carbon has been replaced, while the hydrogen atom of the hydroxyl group on the 3-position carbon and that on the 6-position carbon have been replaced by methyl groups; (2) a degree of substitution of hydroxypropyl or methoxypropyl group by which the hydrogen atom of the hydroxyl group on the 2-position carbon has been replaced, while the hydrogen atom of the hydroxyl group on the 3-position carbon has been replaced by a methyl group and the hydrogen atom of the hydroxyl group on the 6-position carbon has been unsubstituted; (3) a degree of substitution of hydroxypropyl or methoxypropyl group by which the hydrogen atom of the hydroxyl group on the 2-position carbon has been replaced, while the hydrogen atom of the hydroxyl group on the 6-position carbon has been replaced by a methyl group and the hydrogen atom of the hydroxy
- the molar substitution 3-position MS of hydroxypropyl groups by which the hydrogen atom of the hydroxyl group on the 3-position carbon of each glucose unit has been directly replaced specifically means that the hydrogen atom of the hydroxyl group on the 3-position carbon, among three substitutable hydroxyl groups of each glucose unit, has been replaced by hydroxypropyl or methoxypropyl group.
- the 3-position MS specifically means a total of the following degrees of substitution: (1) a degree of substitution of hydroxypropyl or methoxypropyl group by which the hydrogen atom of the hydroxyl group on the 3-position carbon has been replaced, while the hydrogen atom of the hydroxyl group on the 2-position carbon and that on the 6-position carbon have been replaced by methyl groups; (2) a degree of substitution of hydroxypropyl or methoxypropyl group by which the hydrogen atom of the hydroxyl group on the 3-position carbon has been replaced, while the hydrogen atom of the hydroxyl group on the 2-position carbon has been replaced by a methyl group and the hydrogen atom of the hydroxyl group on the 6-position carbon has been unsubstituted; (3) a degree of substitution of hydroxypropyl or methoxypropyl group by which the hydrogen atom of the hydroxyl group on the 3-position carbon has been replaced, while the hydrogen atom of the hydroxyl group on the 6-position carbon has been replaced by a methyl group and the hydrogen atom of the hydroxy
- the molar substitution 2-position MS of hydroxypropyl group by which the hydrogen atom of the hydroxyl group on the 2-position carbon of each glucose unit has been directly replaced and the molar substitution 3-position MS of hydroxypropyl group by which the hydrogen atom of the hydroxyl group on the 3-position carbon of each glucose unit has been replaced, are measured by the HPMC substitution position analysis as described in Macromolecules, 20, 2413(1987 ) or Journal of Fiber Science and Technology, 40, T-504(1984 ), subsequently to deacylation (deacylation method) of HPMCAS as described in WO2013/154607 .
- the deacylation of the HPMCAS is carried out by the method comprising the steps, in this order, of: dissolving 10 mg of the HPMCAS in 4 mL of dimethylsulfoxide (DMSO) in a nitrogen atmosphere with stirring at 90°C for 2 hours; adding 200 mg of sodium hydroxide powder thereto and stirring the resulting mixture in a nitrogen atmosphere for 45 minutes; adding 500 ⁇ L of water thereto and stirring at 60°C for one hour; further adding 2.5 mL of water thereto and stirring the resulting mixture overnight at 60°C; dialyzing the mixture for 2 days with a dialysis tube (product of Fisher Scientific, made of a regenerated cellulose, tubing type of Tl, and cut-off molecular weight of 3500); and freeze-drying the content of the tube after dialysis to obtain hydroxypropyl methyl cellulose having acetyl and succinyl groups removed for deacylation.
- DMSO dimethylsulfoxide
- the HPMC substitution position analysis comprises the steps, in this order, of: subjecting 50 mg of the above deacylated hydroxypropyl methyl cellulose to addition of 2 mL of a 3% by weight aqueous sulfuric acid solution and hydrolysis at 140°C for 3 hours; adding about 0.7 g of barium carbonate thereto for neutralization; adding 3 mL of methanol thereto to dissolve the resulting hydrolysate to obtain a dispersion; subjecting the dispersion to centrifugation at 500G to obtain a supernatant; filtering the supernatant through a filter having 0.45- ⁇ m openings to obtain a filtrate; subjecting the filtrate to addition of 120 ⁇ L of solution obtained by dissolving 1.5 g of NaBH4 in 10 mL of 0.2N aqueous NaOH solution, and the glucose ring reduction at 37 to 38°C for one hour; adding 100 ⁇ L of acetic acid thereto; removing the solvent from the resulting
- the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 2-position carbon of each glucose unit has been directly replaced
- the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 3-position carbon of each glucose unit has been directly replaced.
- Each detected peak is identified on basis of the structure of each decomposed component which has been analyzed by a mass analyzer beforehand.
- the molar substitution of a methyl group of the HPMCAS is not particularly limited. It is preferably from 0.70 to 2.90, more preferably from 1.00 to 2.40, still more preferably from 1.4 to 2.0.
- the molar substitution of a hydroxypropyl group of the HPMCAS is not particularly limited. It is preferably from 0.20 to 1.50, more preferably from 0.20 to 1.0, still more preferably from 0.20 to 0.80.
- the molar substitution of an acetyl group of the HPMCAS is not particularly limited. It is preferably from 0.10 to 2.50, more preferably from 0.10 to 1.00, still more preferably from 0.40 to 0.95.
- the molar substitution of a succinyl group of the HPMCAS is not particularly limited. It is preferably from 0.10 to 2.50, more preferably from 0.10 to 1.00, still more preferably from 0.10 to 0.60.
- each substituent of the HPMCAS including the hydroxypropyl group and the other groups may be measured using a method described under the heading of "hypromellose acetate succinate", official monographs, Supplement I of the Japanese Pharmacopoeia 16th Editi on.
- the viscosity at 20°C of a dilute (0.1 mol/L) aqueous sodium hydroxide solution containing 2% by weight of the HPMCAS is preferably from 1.1 to 20 mPa ⁇ s, more preferably from 1.5 to 3.6 mPa ⁇ s.
- the viscosity is less than 1.1 mPa ⁇ s, the mist generated during spray coating may become small so that the recovery percentage may be reduced.
- the viscosity is more than 20 mPa ⁇ s, an increase in viscosity of the liquid composition may markedly deteriorate the productivity during spray coating.
- the viscosity may be measured by the method described in General Tests of HPMCAS in the Japanese Pharmacopoeia 16th Editi on.
- the transmittance of aqueous alkali solution of HPMCAS for example, the transmittance of aqueous alkali solution of HPMCAS obtained by dissolving the HPMCAS in aqueous ammonia to have an HPMCAS concentration of 10% by weight is preferably 70% or more, more preferably 75% or more, still more preferably 78% or more from the standpoint of reducing the amount of undissolved and semi-dissolved materials.
- aqueous alkali solution examples include aqueous ammonia, an aqueous monoethanolamine solution, and an aqueous sodium hydroxide solution.
- the aqueous alkali solution is preferably aqueous ammonia.
- the concentration of the aqueous alkali solution may be appropriately selected in accordance with the concentration of a carboxyl group.
- the aqueous alkali solution is preferably added in such an amount that the neutralization degree of the HPMCAS described later becomes preferably 80 mol% or more, more preferably from 95 to 105 mol%.
- the transmittance of aqueous alkali solution of HPMCAS is measured by the method comprising the steps of: adding the HPMCAS to the aqueous alkali solution to have an HPMCAS concentration of 10% by weight while stirring with a propeller-type stirrer at about 400 rpm and then continuously stirring the resulting mixture for 3 hours to obtain an aqueous alkali solution containing the HPMCAS at a concentration of 10% by weight; and measuring the transmittance of the obtained aqueous alkali solution adjusted to 20°C with a transmittance-measuring apparatus (photoelectric colorimeter "PC-50", product of Kotaki Manufacturing Co.) equipped with a 720-nm filter and a 20-mm cell.
- a transmittance-measuring apparatus photoelectric colorimeter "PC-50", product of Kotaki Manufacturing Co.
- a composition comprising the HPMCAS and a solvent is used, for example, as a coating composition for coating a drug.
- the coating composition comprising the HPMCAS and a solvent include an alkali-neutralized aqueous coating composition in which the HPMCAS is partially neutralized with an aqueous alkali solution.
- the HPMCAS is an enteric base and contains carboxyl groups which prevent the HPMCAS from dissolving in an acidic liquid.
- the alkali-neutralized aqueous coating composition can be obtained by adding an aqueous alkali solution to the HPMCAS in an amount necessary for partially neutralizing the carboxyl groups of the HPMCAS and stirring for preferably about 30 minutes to allow the reaction of the HPMCAS with the alkali to proceed sufficiently.
- the type and the concentration of the aqueous alkali solution are same as those used for the above-described measurement of transmittance.
- an aqueous ammonia is preferred from the standpoint of almost no alkali salt residue because of ammonia removal due to evaporation of ammonia in a drying step of a coating procedure.
- the alkali-neutralized aqueous coating composition may be obtained by the method comprising the steps of: adding the HPMCAS to purified water for dispersing to obtain a mixture; and dispersing while subjecting the mixture to the above-described partial neutralization; wherein propeller stirring or a homogenizer is used for both steps of dispersing.
- the object liquid is stirred relatively mildly to prevent the stirring from generating air bubbles and agglomeration of the HPMCAS.
- the revolution speed in propeller stirring is preferably from 100 to 1200 rpm.
- the revolution speed in homogenizer is preferably from 500 to 10000 rpm.
- the neutralization degree of HPMCAS with the aqueous alkali solution means a ratio of an actually added amount of an alkali to an amount of the alkali required for completely (i.e. 100%) neutralizing the carboxyl groups of the HPMCAS.
- the neutralization degree of HPMCAS with the aqueous alkali solution is preferably 80 mol% or more, more preferably from 95 to 105 mol% based on the carboxyl groups of the HPMCAS.
- an alkali is added to neutralize the HPMCAS for dissolution of the HPMCAS in water to obtain an HPMCAS-containing coating solution.
- an alkali is added in an amount equivalent to the amount of the carboxyl groups of HPMCAS to be neutralized, the HPMCAS can theoretically dissolve.
- the HPMCAS sometimes fails to dissolve completely even by the addition of the equivalent amount of alkali.
- the alkali is added further so that the preferable upper limit exceeds 100 mol% and becomes 105 mol%.
- neutralization degree as used herein therefore does not mean an actually neutralized degree, but rather means an index amount of an alkali added, compared with the equivalent amount in which the HPMCAS is theoretically neutralized.
- the neutralization degree When the neutralization degree is less than 80 mol%, dissolution of the HPMCAS may become insufficient. When the neutralization degree is more than 105 mol%, sufficient acid resistance may not be maintained because of enhancement in water introduction due to remaining of an alkali salt. In addition, since the viscosity of the coating composition to be produced depends also on the concentration of the HPMCAS dissolved in the solution, an increase in neutralization degree may limit the concentration of the coating composition which allows coating operation.
- the coating composition thus obtained may comprise a pharmaceutically acceptable various type of additive, including a plasticizer such as triacetin and triethyl citrate; a lubricant such as talc and magnesium stearate; a dispersing agent such as sodium lauryl sulfate; a pigment such as titanium oxide and iron oxide; and an anti-foaming agent such as silicone resin.
- a plasticizer such as triacetin and triethyl citrate
- a lubricant such as talc and magnesium stearate
- a dispersing agent such as sodium lauryl sulfate
- a pigment such as titanium oxide and iron oxide
- an anti-foaming agent such as silicone resin.
- the viscosity of the coating composition is not particularly limited insofar as the viscosity is within a range to allow spraying to coat the composition.
- the viscosity at 20°C of the coating composition is preferably 200 mPa ⁇ s or less, more preferably 100 mPa ⁇ s or less, particularly preferably 50 mPa ⁇ s or less.
- the preferable lower limit is 1 mPa ⁇ s.
- the viscosity is more than 200 mPa ⁇ s, it may be difficult to feed the coating solution to a pump and a spray gun so that the smooth coating operation may be disturbed.
- the viscosity can be measured using a viscosity measurement method described in the Japanese Pharmacopoeia 16th Editi on.
- the coating composition is used for coating the periphery of a drug-containing core by a conventionally known coating apparatus to produce a solid preparation.
- Examples of the solid preparation produced using the coating composition include tablets, granules, fine granules and capsules, and further include orally disintegrating tablets.
- the solid preparation may comprise, in addition to a drug-containing particle, a various type of additive which can be conventionally used in this field, such as an excipient, a binder, a disintegrant, a lubricant, an anti-aggregation agent and a dissolution adjuvant of a pharmaceutical compound.
- Examples of the coating method include a method of applying the coating composition to a drug-containing core.
- the coating apparatus is not particularly limited. Examples thereof may include a pan coater, a fluidized bed coater and a tumbling fluidized bed coater.
- the composition comprising the HPMCAS and a solvent may not be limited to being used as the coating composition.
- it is also used in preparation of a solid dispersion.
- the solid dispersion is prepared by removing the solvent from a solution or dispersion comprising the HPMCAS, a drug and an optional component such as an excipient, a binder, a disintegrant, a lubricant and an anti-aggregation agent.
- the solvent may be removed, for example, by evaporation to dryness or by spray drying.
- spray drying widely means dividing (atomizing) a solution mixture containing a poorly water-soluble drug into small liquid droplets and removing a solvent rapidly from the liquid droplets by evaporation.
- the liquid droplets are mixed with a high-temperature drying gas, or the pressure in a solvent removal apparatus is maintained to be a partial vacuum.
- Examples of the solvent to be used in preparation of the solid dispersion include acetone, methanol, ethanol, isopropanol, methyl acetate, ethyl acetate, tetrahydrofuran, dichloromethane and mixtures thereof.
- Acetone is particularly preferred from the standpoint of solubility or dispersibility.
- alkali cellulose is obtained, for example, by impregnating a predetermined amount of pulp with an alkali metal hydroxide solution such as an aqueous sodium hydroxide solution.
- the pulp to be used in the invention is the same as a usual raw material for cellulose ether such as wood pulp or linter pulp.
- the pulp may be used in any form such as powder, sheet or chip form.
- the polymerization degree of the pulp can be appropriately selected depending on the intended viscosity of cellulose ether.
- the alkali cellulose is reacted with a required amount of a methyl etherifying agent such as methyl chloride and a required amount of a hydroxypropyl etherifying agent such as propylene oxide to produce hydroxypropyl methyl cellulose.
- a methyl etherifying agent such as methyl chloride
- a hydroxypropyl etherifying agent such as propylene oxide
- Each glucose unit of cellulose has three substitutable hydroxyl groups.
- the reactivity is highest at the hydroxyl group on the 2-position carbon of the glucose unit, the reactivity is inferior thereto at the hydroxyl group on the 6-position carbon; and the reactivity is lowest at the hydroxyl group on the 3-position carbon.
- the reactivity is highest at the hydroxyl group on the 6-position carbon of the glucose unit, the reactivity is inferior thereto at the hydroxyl groups on the 2- and 3-position carbons, where the reactivity at the hydroxyl group on the 2-position carbon and that at the hydroxyl group on the 3-position carbon are on the same level.
- the reaction with the hydroxypropyl etherifying agent is preferably preceded by the reaction with the methyl etherifying agent, wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 2-position carbon of each glucose unit has been directly replaced, and the 3-postion MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 3-position carbon of each glucose unit has been directly replaced.
- a preceding reaction with the methyl etherifying agent is carried out.
- the methyl etherifying agent and the hydroxypropyl etherifying agent may be added simultaneously, or either one of the methyl etherifying agent and the hydroxypropyl etherifying agent may be added first.
- reaction ratio of hydroxypropyl etherifying agent is 40% or less, preferably more than 0% but not more than 40% at the time when the reaction ratio of methyl etherifying agent is 30%; or the reaction ratio of hydroxypropyl etherifying agent is 90% or less, preferably more than 0% but not more than 90% at the time when the reaction ratio of methyl etherifying agent is 50%.
- reaction ratio of methyl etherifying agent means a molar ratio of the reacted amount of methyl etherifying agent to the stoichiometric amount of methyl etherifying agent at a certain time.
- the reaction with the methyl chloride consumes an equimolar amount of an alkali so that the reaction ratio of methyl chloride means a mole ratio of a presently reacted amount of the methyl chloride to an initial alkali amount in a reactor.
- an amount of the methyl etherifying agent is generally equal to or more than the amount stoichiometric to the amount of the alkali to increase the efficiency of the methyl etherification.
- reaction ratio of methyl etherifying agent means a molar ratio of the reacted amount of hydroxypropyl etherifying agent to the total amount of hydroxypropyl etherifying agent to be added into the reactor at a certain time.
- the methyl etherification can take the amount of the alkali as a criterion of a stoichiometric amount
- the hydroxypropyl etherification takes the total amount of the hydroxypropyl etherifying agent added to the reactor as a criterion of the stochiometic amount. It is because the alkali works as a catalyst in the hydroxypropyl etherification and is not consumed in a stoichiometric manner.
- the reaction ratio of methyl etherifying agent or the reaction ratio of hydroxypropyl etherifying agent may be determined using a method comprising the step of removing and recovering the methyl etherifying agent or hydroxypropyl etherifying agent quickly from the reactor to determine the amount of the methyl etherifying agent or hydroxypropyl etherifying agent present in the reactor just before the removal and recovery, wherein the reaction ratio is calculated by dividing the reacted amount of methyl etherifying agent by the stoichiometric amount or dividing the reacted amount of hydroxypropyl etherifying agent by the total amount of hydroxypropyl etherifying agent to be added into the reactor.
- the reaction ratios may also be determined using simulation based on chemical reaction rate equations found by an experiment.
- the reaction efficiency of competitive etherification with the hydroxypropyl etherifying agent decreases so that the reaction ratio of hydroxypropyl etherifying agent at the time when the reaction ratio of methyl etherifying agent is 30% or 50% can be used as an index of the preceding reaction with the methyl etherifying agent.
- the methyl etherifying agent is fed for preferably from 5 to 80 minutes, more preferably from 5 to 50 minutes.
- the hydroxypropyl etherifying agent is fed for preferably from 10 to 90 minutes, more preferably from 30 to 90 minutes.
- the feed time of the methyl etherifying agent does not contain a time lag between the start of feeding of the hydroxypropyl etherifying agent and the start of feeding of the methyl etherifying agent; and that the feed time of the hydroxypropyl etherifying agent does not contain a time lag between the start of feeding of the methyl etherifying agent and the start of feeding of the hydroxypropyl etherifying agent.
- the reaction ratio of hydroxypropyl etherifying agent becomes 40% or less at the time when the reaction ratio of methyl etherifying agent is 30%, or the reaction ratio of the hydroxypropyl etherifying agent becomes 90% or less at the time when the reaction ratio of the methyl etherifying agent is 50%.
- the hydroxypropyl methyl cellulose having a ratio of 2-position MS to 3-position MS of 1.2 or less wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 2-position carbon of each glucose unit has been directly replaced, and the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 3-position carbon of each glucose unit has been directly placed.
- the etherification reaction temperature is not particularly limited insofar as the reaction ratio of the hydroxypropyl etherifying agent at the time when the reaction ratio of the methyl etherifying agent is 30% or 50% falls within the above-mentioned range.
- the temperature is in a range of from 50 to 80°C at the initial stage of the reaction (at the time when feeding of either of the etherifying agents is started), also in the range of from 50 to 80°C at 0.5 hour later, in the range of from 55 to 90°C at 1 hour later, in the range of from 65 to 110°C at 1.5 hours later, and in the range of from 80 to 110°C at 2 hours later.
- the temperature thereafter is preferably kept at from 80 to 110°C.
- the reaction may be terminated when the etherification reaction is completed irrespective of the above-described schedule.
- the hydroxypropyl methyl cellulose can be produced under conditions similar to those of a known method except for the reaction ratio of hydroxypropyl etherifying agent at the time when the reaction ratio of the methyl etherifying agent is 30% or is 50%.
- the hydroxypropyl methyl cellulose obtained above can be used, for example, as a coating composition after being subjected to an optional depolymerization reaction for viscosity adjustment.
- the depolymerization reaction may be carried out by the method described in Japanese Patent Application Examined Publication No. 4-076361 .
- the depolymerization reaction may be carried out by the method comprising the steps of: bringing the hydroxypropyl methyl cellulose into contact with an aqueous hydrogen chloride solution for the reaction at a temperature of 40 to 85°C in such an amount that hydrogen chloride becomes from 0.1 to 1% by weight of the amount of the hydroxypropyl methyl cellulose and a water content in the reaction system becomes from 3 to 8% by weight; and then removing the hydrogen chloride.
- the viscosity at 20°C of a 2% by weight aqueous hydroxypropyl methyl cellulose solution after the depolymerization reaction is measured in accordance with the viscosity measurement by capillary tube viscometer described in the Japanese Pharmacopoeia 16th Editi on. It is preferably from 1.2 to 30 mPa ⁇ s, more preferably from 1.6 to 4.5 mPa ⁇ s.
- the HPMCAS may be produced using the hydroxypropyl methyl cellulose as a starting material in accordance with, for example, the method described in Japanese Patent Application Unexamined Publication No. 54-061282A .
- the method comprises the steps of: subjecting the hydroxypropyl methyl cellulose dissolved in glacial acetic acid to addition of acetic anhydride and succinic anhydride as esterifying agents and addition of sodium acetate as a reaction catalyst, while heating for the reaction; adding a large amount of water to the reaction mixture to allow HPMCAS to precipitate after completion of the reaction; washing the resulting precipitate with water; and drying the washed precipitate.
- the resulting HPMCAS also has a ratio of 2-position MS to 3-position MS of 1.2 or less, wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 2-position carbon of each glucose unit has been directly replaced, and the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 3-position carbon of each glucose unit has been directly replaced.
- the 2029 g of the alkali cellulose (containing 570 g of cellulose portion) was placed in a pressure vessel (i.e. reactor) equipped with a plow share type internal stirring blade.
- the reactor was vacuumed to -97 kPa, and then purged with nitrogen to return to the atmospheric pressure. Then the reactor was vacuumed again to -97 kPa.
- methyl chloride was fed into the reactor with a pressure pump in 30 minutes.
- feeding of propylene oxide into the reactor started with a pressure pump, and 491 g of the propylene oxide was fed into the reactor in 50 minutes.
- the inside temperature of the reactor was adjusted to from 50 to 80°C at the start, a range of from 50 to 80°C at 0.5 hour later, a range of from 55 to 90°C at one hour later, a range of from 65 to 110°C at 1.5 hours later, and a range of from 80 to 110°C at two hours later, to complete the etherification reaction.
- reaction ratio of propylene oxide was 25.5% at the time when the reaction ratio of methyl chloride was 30%, and the reaction ratio of propylene oxide was 36% at the time when the reaction ratio of methyl chloride was 50%.
- the reaction product was washed with hot water of 95°C or more and then dried using a small-sized Wiley mill.
- the hydroxypropyl methyl cellulose thus obtained had an average degree of substitution (DS) of methyl groups of 1.89 and molar substitution (MS) of hydroxypropyl groups of 0.24 as a result of analyses in accordance with the method of analyzing the degree of substitution of hypromellose (hydroxypropyl methyl cellulose) in the Japanese Pharmacopoeia 16th Editi on.
- the 450 g of the hydroxypropyl methyl cellulose was placed in a 10-L Henschel mixer and mixed at 200 rpm, while spraying an aqueous hydrochloric acid having a concentration of 10% by weight thereto in such an amount that 3 g of hydrogen chloride component became added thereto.
- the resulting mixture was transferred into a 2-L glass reactor, and subjected to a depolymerization reaction until the viscosity at 20°C of a 2% by weight aqueous solution became 3.4 mPa ⁇ s while rotating the reactor in a water bath of 75°C. Then hydrogen chloride and water were evaporated for 30 minutes under reduced pressure of 80 mmHg to obtain the depolymerized hydroxypropyl methyl cellulose.
- a ratio of 2-position MS to 3-position MS of the HPMCAS was determined, wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 2-position carbon of each glucose unit has been replaced, and the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 3-position carbon of each glucose unit has been replaced.
- the HPMCAS was deacylated by the HPMCAS deacylation method and then subjected to the HPMC substitution position analysis to find the ratio of 2-position MS to 3-position MS. The ratio was found to be 0.65.
- the transmittance of the HPMCAS was measured using an aqueous ammonia solution having the HPMCAS dissolved therein.
- the aqueous ammonia solution of the HPMCAS is prepared as follows.
- the HPMCAS (26 g) was dispersed in 228.8 g of purified water at room temperature while stirring at a rate of 400 rpm with a propeller type stirrer to obtain an aqueous HPMCAS suspension.
- the resulting suspension was subjected to addition of 5.21 g of a 10% by weight aqueous ammonia solution while stirring with the propeller type stirrer, to neutralize 100 mol% of the carboxyl groups of the HPMCAS.
- HMPCAS was obtained in the same manner as in Example 1 except that the feed time of methyl chloride was 34 minutes and the amount of propylene oxide fed was 445 g. The results are shown in Table 1.
- HMPCAS was obtained in the same manner as in Example 1 except that the feed time of methyl chloride was 50 minutes, the feed time of propylene oxide was 33 minutes, and the amount of propylene oxide fed was 348 g. The results are shown in Table 1.
- HMPCAS was obtained in the same manner as in Example 1 except that the feed time of methyl chloride was 80 minutes, the feed time of propylene oxide was 10 minutes, and the amount of propylene oxide fed was 268 g. The results are shown in Table 1.
- HMPCAS was obtained in the same manner as in Example 1 except that the feed time of methyl chloride was 80 minutes, the feed time of propylene oxide was 10 minutes, the amount of propylene oxide fed was 268 g, and feeding of methyl chloride was started 10 minutes after feeding of propylene oxide was started.
- the results are shown in Table 1.
- HMPCAS was obtained in the same manner as in Example 1 except that the feed time of methyl chloride was 80 minutes, the feed time of propylene oxide was 10 minutes, the amount of propylene oxide fed was 268 g, and feeding of methyl chloride was started 15 minutes after feeding of propylene oxide was started.
- the results are shown in Table 1.
- HMPCAS was obtained in the same manner as in Example 1 except that the feed time of methyl chloride was 80 minutes, the feed time of propylene oxide was 10 minutes, the amount of propylene oxide fed was 268 g, and feeding of methyl chloride was started 20 minutes after feeding of propylene oxide was started.
- the results are shown in Table 1.
- HMPCAS was obtained in the same manner as in Example 1 except that the feed time of methyl chloride was 80 minutes, the feed time of propylene oxide was 10 minutes, the amount of propylene oxide fed was 268 g, and feeding of methyl chloride was started 27 minutes after feeding of propylene oxide was started.
- Table 1 amount fed feed time start of feeding of methyl chloride *1 reaction ratio of propylene oxide at 30%*2 reaction ratio of propylene oxide at 50%*3 molar substitution ratio of 2-position MS to 3-position MS transmittance in aq.
- Each HPMCAS of Examples 1 to 5 having a ratio of 2-position MS to 3-position MS of 1.2 or less exhibits the transmittance as high as about 75%, wherein the 2-position ratio means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 2-position carbon of each glucose unit has been replaced, and the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on the 3-position carbon of each glucose unit has been replaced.
- each HPMCAS of Comparative Examples 1 to 3 having a ratio of 2-position MS to 3-position MS of more than 1.2 exhibits a relatively low transmittance with very turbid appearance. It is evident that since the ratio of 2-positiion MS to 3-posititon MS of HPMCAS is lowered, the solubility of HPMCAS is increased.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016048254 | 2016-03-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3216808A1 EP3216808A1 (en) | 2017-09-13 |
EP3216808B1 true EP3216808B1 (en) | 2018-10-03 |
Family
ID=58277166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17159962.4A Active EP3216808B1 (en) | 2016-03-11 | 2017-03-08 | Hypromellose acetate succinate, method for producing the same and composition containing the same |
Country Status (7)
Country | Link |
---|---|
US (2) | US9884922B2 (ko) |
EP (1) | EP3216808B1 (ko) |
JP (1) | JP6670778B2 (ko) |
KR (1) | KR102240063B1 (ko) |
CN (1) | CN107177006B (ko) |
PT (1) | PT3216808T (ko) |
TW (1) | TWI703162B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108245700A (zh) * | 2018-01-22 | 2018-07-06 | 河南汇博医疗股份有限公司 | 一种羟丙基甲基纤维素壳聚糖薄膜敷料及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1468048B2 (de) * | 1964-11-28 | 1975-02-20 | Henkel & Cie Gmbh, 4000 Duesseldorf | Verfahren zur Herstellung von Hydroxypropyl-methylcellulosen |
JPS5951562B2 (ja) | 1977-10-25 | 1984-12-14 | 信越化学工業株式会社 | セルロ−スエ−テルの酸性サクシニルおよび脂肪族モノアシル混成エステルの製造方法 |
US4685342A (en) | 1985-05-15 | 1987-08-11 | Brackett Douglas C | Device for converting linear motion to rotary motion or vice versa |
JPS6281402A (ja) * | 1985-10-07 | 1987-04-14 | Shin Etsu Chem Co Ltd | セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法 |
JP5052112B2 (ja) * | 2005-12-27 | 2012-10-17 | 信越化学工業株式会社 | アルカリセルロース及びセルロースエーテルの製造方法 |
JP5588762B2 (ja) * | 2009-12-15 | 2014-09-10 | 信越化学工業株式会社 | 高い熱ゲル強度を有するヒドロキシプロピルメチルセルロースを含む食品 |
US9040033B2 (en) * | 2010-06-14 | 2015-05-26 | Dow Global Technologies Llc | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
US9580581B2 (en) * | 2010-10-12 | 2017-02-28 | Dow Global Technologies Llc | Cellulose ethers and their use |
US20120251588A1 (en) * | 2011-03-30 | 2012-10-04 | Miyuki Fukasawa | Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation |
WO2012173838A1 (en) * | 2011-06-14 | 2012-12-20 | Dow Global Technologies Llc | Food composition comprising a cellulose ether |
US9051218B2 (en) * | 2011-12-01 | 2015-06-09 | Dow Global Technologies Llc | Building composition comprising cellulose ether |
WO2013154607A1 (en) | 2012-04-11 | 2013-10-17 | Dow Global Technologies Llc | Esterified cellulose ethers having a specific substituent distribution |
JP6456849B2 (ja) * | 2013-03-01 | 2019-01-23 | ハーキュリーズ・インコーポレーテッドHercules Incorporated | 高められた性能及び改善された加工性を有する医薬組成物 |
KR102110119B1 (ko) * | 2013-03-07 | 2020-05-14 | 다우 글로벌 테크놀로지스 엘엘씨 | 저점도 및 고분자량의 신규한 에스테르화된 셀룰로스 에테르 |
KR102286952B1 (ko) * | 2013-12-31 | 2021-08-09 | 롯데정밀화학 주식회사 | 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말 |
-
2017
- 2017-03-03 US US15/449,725 patent/US9884922B2/en active Active
- 2017-03-08 PT PT17159962T patent/PT3216808T/pt unknown
- 2017-03-08 EP EP17159962.4A patent/EP3216808B1/en active Active
- 2017-03-08 KR KR1020170029364A patent/KR102240063B1/ko active IP Right Grant
- 2017-03-10 TW TW106108008A patent/TWI703162B/zh active
- 2017-03-13 CN CN201710147250.1A patent/CN107177006B/zh active Active
- 2017-03-13 JP JP2017047205A patent/JP6670778B2/ja active Active
- 2017-12-22 US US15/853,164 patent/US10233259B2/en active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
JP6670778B2 (ja) | 2020-03-25 |
KR20170106214A (ko) | 2017-09-20 |
CN107177006A (zh) | 2017-09-19 |
US9884922B2 (en) | 2018-02-06 |
CN107177006B (zh) | 2021-02-19 |
TWI703162B (zh) | 2020-09-01 |
PT3216808T (pt) | 2018-11-09 |
US20180118854A1 (en) | 2018-05-03 |
US20170260296A1 (en) | 2017-09-14 |
EP3216808A1 (en) | 2017-09-13 |
US10233259B2 (en) | 2019-03-19 |
JP2017165963A (ja) | 2017-09-21 |
KR102240063B1 (ko) | 2021-04-15 |
TW201802122A (zh) | 2018-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2627676B1 (en) | Novel cellulose ethers and their use | |
EP2836205B1 (en) | Esterified cellulose ethers having a specific substituent distribution | |
KR102138545B1 (ko) | 고분자량 및 높은 균일성을 갖는 신규한 에스테르화된 셀룰로즈 에테르 | |
US9382336B2 (en) | Method for preparing cellulose ether having low degree of polymerization and cellulose ether prepared thereby | |
EP3216808B1 (en) | Hypromellose acetate succinate, method for producing the same and composition containing the same | |
JP4410581B2 (ja) | 溶解性の改善されたセルロース誘導体の製造製法 | |
EP3567058B1 (en) | Hypromellose phthalate and method for producing the same | |
JP3212531B2 (ja) | 低置換度ヒドロキシプロピルセルロース、低置換度ヒドロキシプロピルセルロース崩壊剤及びその製造方法 | |
EP3294777B1 (en) | Process for producing esterified cellulose ethers of very high molecular weight and low viscosity | |
US11879022B2 (en) | Method for producing depolymerized cellulose ether | |
KR101156365B1 (ko) | 용해성이 개선된 셀룰로오스 유도체의 제조 방법 | |
JP2014111796A5 (ja) | 高い熱ゲル化強度を有するヒドロキシプロピルメチルセルロース及びその製造方法 | |
KR20070017390A (ko) | 저분자량 에틸셀룰로오즈의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180305 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C08B 13/00 20060101AFI20180322BHEP |
|
INTG | Intention to grant announced |
Effective date: 20180420 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: CH Ref legal event code: NV Representative=s name: MICHELI AND CIE SA, CH Ref country code: AT Ref legal event code: REF Ref document number: 1048491 Country of ref document: AT Kind code of ref document: T Effective date: 20181015 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017000564 Country of ref document: DE Ref country code: IE Ref legal event code: FG4D Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Ref document number: 3216808 Country of ref document: PT Date of ref document: 20181109 Kind code of ref document: T Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20181016 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1048491 Country of ref document: AT Kind code of ref document: T Effective date: 20181003 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190103 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190203 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190103 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190104 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017000564 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 |
|
26N | No opposition filed |
Effective date: 20190704 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190308 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190308 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170308 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181003 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230512 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20240209 Year of fee payment: 8 Ref country code: NL Payment date: 20240214 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240130 Year of fee payment: 8 Ref country code: GB Payment date: 20240201 Year of fee payment: 8 Ref country code: PT Payment date: 20240307 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20240212 Year of fee payment: 8 Ref country code: FR Payment date: 20240213 Year of fee payment: 8 Ref country code: BE Payment date: 20240216 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240401 Year of fee payment: 8 |